
Nephrotic Syndrome, Type 9: Navigating Genetic Testing for a Deeper Understanding
Explore genetic testing's role in managing nephrotic syndrome type 9. Learn about identifying mutations, predicting disease progression, and personalized treatment.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore genetic testing's role in managing nephrotic syndrome type 9. Learn about identifying mutations, predicting disease progression, and personalized treatment.

Explore genetic testing for NBIA6, a rare neurodegenerative disorder. Gain insights into symptoms, personalized treatment, and family planning advantages.

Unlock the power of genetic testing for diagnosing neuronopathy, distal hereditary motor, type 2D. Ensure early intervention, tailored management, and informed family planning.

Explore Hereditary Sensory Neuropathy Type 1F, its genetic roots, and how advances in genetic testing offer insights into diagnosis, treatment, and family planning.

Explore genetic testing's impact on diagnosing CEP19 deficiency-related obesity. Early diagnosis, personalized plans, and family insights improve patient outcomes.

Explore the impact of SIM1 deficiency on obesity, the critical role of genetic testing for early diagnosis, personalized treatment, and family planning insights.

Explore the role of genetic testing in diagnosing Otofaciocervical Syndrome 2, revealing insights into PAX1 mutations and personalized treatment strategies.

Explore Pachyonychia Congenita 3, a rare genetic disorder. Learn how genetic testing aids diagnosis, personalized treatment, and genetic counseling for families.